Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis? Source: Eur Respir J 2016; 48: 279-281 Year: 2016
Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis? Source: Eur Respir J 2016; 48: 281-282 Year: 2016
Does a predominant clinical COPD phenotype predict different outcome responses to pulmonary rehabilitation? Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012
Early decrease of forced vital capacity is a good prediction tool for prognosis in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008
The experience of long-term prognosis evaluation of childhood asthma Source: Eur Respir J 2005; 26: Suppl. 49, 164s Year: 2005
Does clinical score evaluation improve management in bronchiolitis patients? Source: Eur Respir J 2007; 30: Suppl. 51, 391s Year: 2007
Determining the best diagnostic biomarker for sepsis and prognosis assessment Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012
Clinical phenotyping of COPD patients: a simple tool with prognosis value Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018
Alpha-1-antitrypsine dephiciency. Can we improve prognosis? Source: Annual Congress 2008 - Pulmonary infections in children - rare but important aspects Year: 2008
Recognising poor prognosis community-acquired pneumonia in young adults with simple clinical measurements Source: Eur Respir J 2006; 28: Suppl. 50, 351s Year: 2006
Interleukin-6, but not pentraxin 3, predicts adverse clinical outcomes on short-term prognosis of patients with incipient heart failure Source: Annual Congress 2011 - COPD exacerbation Year: 2011
Low-t3 state a crucial biomarker in determining NIV failure and outcome in pulmonary patient? Source: Annual Congress 2011 - Mechanical ventilation and weaning Year: 2011
How exactly can we predict the prognosis of COPD? Source: Eur Respir J 2006; 28: Suppl. 50, 807s Year: 2006
Emergency presentation of lung cancer patients via A&E increases the chances of having advanced disease stage and worse performance status Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders Year: 2017
Early outcomes in CAP: clinical stability, clinical failure and nonresolving pneumonia Source: Eur Respir Monogr 2014; 63: 205-218 Year: 2014
Cluster phenotyping as an approach to identify COPD patients at risk of poor prognosis. Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018
Impaired pulmonary function and its association with clinical outcomes, exercise capacity and quality of life in children with congenital heart disease Source: Virtual Congress 2020 – Clinical year in review Year: 2020
Dynapenia in COPD exacerbation: what is its relevance in clinical prognosis? Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy Year: 2017
Physicians or prediction rules; who is better at predicting prognosis? Source: Eur Respir J 2007; 30: Suppl. 51, 124s Year: 2007
Bedside evaluation of swallowing function in prolonged weaning patients. Significance of a targeted speech rehabilitation in weaning outcome. Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease Year: 2020